Drug Testing in Nigeria (A) Custom Case Solution & Analysis

1. Evidence Brief (Case Researcher)

Financial Metrics

• Market Size: The Nigerian pharmaceutical market is estimated at $600M (Paragraph 3).
• Cost of Counterfeit Drugs: Estimated at 40% of the total market, equivalent to $240M annually (Paragraph 5).
• Regulatory Fee: NAFDAC registration fee is 50,000 Naira per product (Exhibit 2).

Operational Facts

• Geography: Operations concentrated in Lagos, Abuja, and Kano (Paragraph 8).
• Infrastructure: Cold chain storage is non-existent in 65% of rural pharmacies (Paragraph 12).
• Distribution: 80% of drugs reach consumers through informal open-air markets (Paragraph 14).

Stakeholder Positions

• NAFDAC (Regulatory): Focused on enforcement and brand protection, but constrained by budget (Paragraph 16).
• Local Pharmacies: Skeptical of new authentication technology due to cost (Paragraph 19).
• International Pharma: High interest in brand integrity but wary of Nigerian logistics (Paragraph 21).

Information Gaps

• Specific adoption rates for mobile-based authentication in rural vs. urban settings.
• The exact cost-per-scan for the Sproxil or similar SMS-based verification models.
• Conversion metrics regarding consumer willingness to pay for verified medications.

2. Strategic Analysis (Strategic Analyst)

Core Strategic Question

How can authentication technology achieve the critical mass necessary to dismantle the counterfeit drug trade when retail infrastructure is fragmented and consumer trust is low?

Structural Analysis

• Buyer Power: High. Consumers are price-sensitive and lack the tools to distinguish between authentic and counterfeit goods.
• Threat of Substitutes: High. Inexpensive, counterfeit medicine is often the only accessible option in rural areas.
• Industry Rivalry: Intense among international firms, but the real competition is the illicit market that operates at a lower cost base.

Strategic Options

• Option 1: Mandatory SMS-based Authentication. Partner with NAFDAC to mandate scratch-off codes on all imported drugs. Trade-off: High regulatory friction vs. high barrier to entry for counterfeiters.
• Option 2: Pharmacy-Led Verification. Incentivize licensed pharmacists to act as gatekeepers. Trade-off: Higher trust vs. limited reach into informal markets.
• Option 3: Direct-to-Consumer Education. Mass media awareness campaigns. Trade-off: High cost vs. slow behavior change.

Preliminary Recommendation

Pursue Option 1. Regulatory mandate is the only mechanism capable of overcoming the fragmented distribution network. It shifts the burden of verification from the consumer to the point of origin.

3. Implementation Roadmap (Implementation Specialist)

Critical Path

1. Secure NAFDAC endorsement for a pilot phase in Lagos.
2. Integrate SMS verification software with major importer inventory systems.
3. Execute a three-month controlled trial in 50 pharmacies.

Key Constraints

• Connectivity: SMS penetration is high, but network reliability in rural areas remains inconsistent.
• Counterfeiter Adaptation: Illicit actors may attempt to replicate scratch-off codes if the authentication platform lacks robust encryption.

Risk-Adjusted Implementation

The pilot must focus on high-volume medications where the cost of verification is negligible compared to the unit price. A contingency fund covering 20% of the project budget is required to address potential technical failures in the SMS gateway.

4. Executive Review and BLUF (Executive Critic)

BLUF

The proposed strategy fails to account for the primary barrier: the illicit market is not a competitor, it is the incumbent. Authentication technology will not succeed if it relies on consumer behavior change in a market where survival dictates purchasing the cheapest available option. The focus must shift from verification to supply chain control. If NAFDAC cannot enforce the mandate at the point of entry, the technology is irrelevant. The company should stop chasing retail adoption and focus exclusively on high-value, high-risk therapeutic categories where brand owners are willing to underwrite the cost of authentication to protect their intellectual property. Abandon the broad market strategy; focus on the top 10% of high-risk imports.

Dangerous Assumption

The assumption that a regulatory mandate will be enforced by a cash-strapped agency (NAFDAC) without significant corruption or inertia.

Unaddressed Risks

• Systemic Corruption: Illicit actors will likely bribe local officials to bypass authentication requirements.
• Operational Friction: The scratch-off code process adds time to every transaction, which pharmacists will resist without financial compensation.

Unconsidered Alternative

Partnering with telecommunications providers to create a subsidized verification system where the cost of the SMS is borne by the pharma company, not the consumer, effectively making verification free at the point of sale.

Verdict: REQUIRES REVISION. The strategy relies too heavily on regulatory enforcement and ignores the economic incentives of the retail channel. Please refine to address the cost-bearing mechanism for the consumer.